Stocks
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 30.0% | 27.7% | 73.9% | 26.9% | 26.8% | |||
| Changes by years, y/y, % | +1pp | -2pp | +46pp | -47pp | 0pp | -1.8% | |||
Sino Biopharmaceutical Limited. EBITDA margin, %
Sino Biopharmaceutical Limited. EBITDA margin, changes, pp
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (quarter values) |
||||
| 2020Q4 | LTM ? | |||
| EBITDA margin, % | ? | 16.6% | ||
| Changes by years, y/y, % | ||||
| Changes by quarters, q/q, % | ||||
